Enliven Therapeutics, Inc. (ELVN)

CIK 1672619 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Enliven Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 4, 20261440001959173-26-006749
Aug 19, 202640001701247-26-000012
Aug 19, 202640001882764-26-000007
Aug 6, 202640001865125-26-000004
Aug 6, 2026SCHEDULE 13G/A0000315066-26-001988
Aug 5, 20268-K0001193125-26-335101
Aug 5, 202610-Q0001193125-26-335155
Aug 4, 20261440001974158-26-000095
Jul 21, 202640001701247-26-000011
Jul 21, 202640001882764-26-000006
Jul 17, 20261440001974158-26-000084
Jul 8, 202640001536368-26-000007
Jun 24, 202640000947871-26-000653
Jun 24, 2026SCHEDULE 13D/A0000947871-26-000651
Jun 22, 20261440000947871-26-000649
Jun 22, 20261440000947871-26-000648
Jun 22, 2026SCHEDULE 13G/A0001172661-26-002461
Jun 22, 202640001882764-26-000005
Jun 22, 202640001701247-26-000010
Jun 22, 20261440000947871-26-000650
Jun 17, 202640000947871-26-000637
Jun 17, 2026SCHEDULE 13D/A0000947871-26-000636
Jun 17, 20261440001974158-26-000074
Jun 15, 20261440000947871-26-000628
Jun 15, 20261440000947871-26-000627